We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Wyeth will respond this month to Form 483 observations from an FDA reinspection of the company’s Guayama, Puerto Rico, manufacturing facility, the firm announced.
As part of its market study into exclusive pharmaceutical distribution contracts, the UK’s Office of Fair Trading (OFT) could launch an investigation into Pfizer’s wholesale distribution contract with Unichem.
Two Pfizer subsidiaries reached separate settlements with the U.S. government to address charges related to the marketing of the human growth hormone Genotropin, Pfizer announced.
As part of a legal settlement, Novartis will assist Bayer Schering Pharma in obtaining FDA validation of Bayer’s outsourced European Betaseron manufacturing facility, Bayer told DGR March 27. The facility is operated by Boehringer Ingelheim.
Merck and Lundbeck announced they are stopping their entire development program for gaboxadol, an investigational new insomnia drug, in the midst of a Phase III clinical trial.
The Centers for Disease Control and Prevention (CDC) is recommending routine Gardasil vaccines for girls females 11–26 to prevent certain strains of the human papillomavirus (HPV), Merck announced.
The American College of Cardiology (ACC) meeting this week will create more controversy about the use of drug-eluting stents, says a report from RBC Capital Markets.
Diabetes patients are being advised to switch from manually coded blood glucose meters to automatically coded meters or receive instructions on coding their meters to avoid errors in insulin dose, according to Bayer Healthcare.